Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...

At ESMO, we presented the results from the phase 3 NIAGARA trial ... And the second one is just back on 2025, just to get a bit more color, if I could, from Pascal or Aradana. You've listed two main ...

Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

I gave some color today on Afirma kind of indicating high ... any of you who paid attention to the stuff we talked about at ESMO, Decipher is moving down the care continuum into prediction ...

The results of the GALAXIES Lung-02 study reported at the ESMO congress in Barcelona showed that the drug – added to GSK's PD-1 inhibitor Jemperli (dostarlimab) – achieved a higher objective ...

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could resurrect the SCAC indication and move Zynyz into the first-line setting to boot. Given in combination with ...

However we see and interpret the world, we are able to do so with the range of colour as they are loaded with that much significance. As Pablo Picasso said, “Colors, like features, follow the changes ...